-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.O1.6 624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Clinical Studies in T/NK Cell Lymphoma Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, Diseases, drug-drug interaction, Lymphoma (any), Non-Biological, Therapies, Combinations, Non-Hodgkin Lymphoma, T-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, infusion, Clinically relevant, transplantation
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Moderators:
Stefan K. Barta, MD, MRCP, MS, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania and Deepa Jagadeesh, MD, MPH, Cleveland Clinic
Disclosures:
Barta: Monsanto: Consultancy; Atara: Honoraria; Seattle Genetics: Honoraria, Research Funding; Janssen: Honoraria; Pfizer: Honoraria; Acrotech: Honoraria. Jagadeesh: Regeneron: Research Funding; Seattle Genetics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Verastem: Membership on an entity's Board of Directors or advisory committees; MEI Pharma: Research Funding; Debiopharm Group: Research Funding.
7:30 AM

Emmanuel Bachy, MD, PhD1*, Vincent Camus2*, Catherine Thieblemont, MD, PhD3, Rene-Olivier Casasnovas, MD4*, Loic Ysebaert, MD, PhD5*, Gandhi Laurent Damaj, MD, PhD6, Stephanie Guidez7*, Gian-Matteo Pica, MD8*, Won Seog Kim, MD, PhD9*, Soon Thye Lim, MBBS, MRCP, FAMS10*, Marc André, MD11*, Alejandro Martin Garcia-Sancho, MD, PhD12*, Maria Jesus Penarrubia Ponce, MD13*, Philipp B. Staber, MD, PhD14, Judith Trotman, FRACP15, Andreas Hüttmann, MD16, Vittorio Stefoni, MD, PhD17*, Alessandro Re, MD18*, Philippe Gaulard, MD, PHD19*, Marie-Helene Delfau-Larue, MD, PhD20*, Laurence De Leval, MD21, Michel Meignan, MD22*, Ju Li, PhD23*, Franck Morschhauser, MD, PhD24* and Richard Delarue, MD25,26

1Hospices Civils De Lyon, Lyon, France
2Department of Hematology, Centre Henri Becquerel, Rouen, France
3Hematology Department, Hospital Saint-Louis, Paris, France
4Department of Hematology, CHU Dijon-Bourgogne and INSERM 1231, Dijon, France
5IUCT Oncopole, Toulouse, France
6CHU de Caen Normandie, Normandie, France
7Service d'Hématologie, CHU de Poiters, Poiters, France
8Department of Hematology, Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France
9Samsung Medical Center, Seoul, Korea, Republic of (South)
10National Cancer Centre Singapore, Singapore, Singapore
11Department of Hematology, CHU UCL Namur, Yvoir, Belgium
12Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
13Hospital Clinico Universitario de Valladolid, Valladolid, Spain
14Division of Hematology, Department of Medicine I, Medical University Vienna, Vienna, Austria
15Concord Repatriation General Hospital, University of Sydney, Concord, Australia
16University of Duisburg-Essen, Essen, Germany
17Policlinico Sant'Orsola-Malpighi, Bologna, Italy
18Hematology Division, Spedali Civili di Brescia, Brescia, Italy
19Department of Pathology and InsermU955, University Hospital Henri Mondor, Créteil, France
20Groupe Hospitalier Mondor, INSERM U955, Creteil, France
21Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
22CHU de Henri Mondor, Créteil, France
23Bristol-Myers Squibb Company, Princeton, NJ
24Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
25Service d’hematologie adultes, Hopital universitaire Necker enfants malades, AP-HP, Paris, France
26Bristol-Myers Squibb Company, Boudry, Switzerland

7:45 AM

Jia Ruan, MD, PhD1, Alison J. Moskowitz, MD2, Neha Mehta-Shah, MD3, Lubomir Sokol, MD, PhD4, Zhengming Chen, PhD, MPH, MS1*, Riyaad Rahim1*, Wei Song1*, Koen Van Besien, MD, PhD1, Steven M. Horwitz, MD5, Sarah C. Rutherford, MD1, Morton Coleman, MD, FACP1*, Ari Melnick, MD1, Giorgio Inghirami, MD1*, Leandro Cerchietti, MD1, John P. Leonard, MD1 and Peter Martin, FRCPC, MD, MS1

1Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
2Memorial Sloan Kettering Cancer Center, New York
3Siteman Cancer Center, Washington University, St. Louis, MO
4Moffitt Cancer Center, Tampa, FL
5Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

8:00 AM

Neha Mehta-Shah, MD1, Ajitha Kommalapati, MD2*, Stephanie Teja, MD3*, Amanda F Cashen, MD4, Parastoo B. Dahi, MD5, Craig S. Sauter, MD6, Alison J. Moskowitz, MD7, Eric D Jacobsen, MD8, Basem M. William, MD, MRCP9, Michael Ozga, MD10, Stefan K. Barta, MD, MRCP, MS11, Alison W. Loren, MD12, Steven Bair, MD13*, Pamela B. Allen, MD, MSc14, Shahana Sulaiman15*, Kevin Song, MD16, Musa Alzahrani, MBBS, MHSc17*, Jia Ruan, MD, PhD18, Koen van Besien, MD, PhD19, Madhav Seshadri, MD20*, Matthew McKinney21, Anne W. Beaven, MD22, Bradley Haverkos, MD, MPH, MS23*, Adam Starr, MD24*, Onder Alpdogan, MD25*, Pierluigi Porcu, MD26, Francine M. Foss, MD27, Yu Tao, MD28* and Steven M. Horwitz, MD7

1Washington University School of Medicine in St. Louis, Saint Louis, MO
2Washington University School of Medicine in St. Louis, St. Louis, MO
3Washington University in St. Louis, Saint Louis
4Washington University School of Medicine, Saint Louis, MO
5Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
9The Ohio State University Comprehensive Cancer Center, Columbus, OH
10The Ohio State University Wexner Medical Center, Columbus, OH
11Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
12Division of Hematology-Oncology/Department of Medicine, Perelman Center for Advanced Medicine, Philadelphia, PA
13University of Pennsylvania, Philadelphia, PA
14Winship Cancer Institute, Emory University, Assistant Professor, Department of Hematology and Medical Oncology, Attending Physician, Bone Marrow and Stem Cell Transplant Center, Emory University Winship Cancer Institute, Decatur, GA
15Emory University Winship Cancer Institute, Atlanta, GA
16BC Cancer Agency, The University of British Columbia, Vancouver, BC, Canada
17Department of Medicine, Oncology Center, College of Medicine, Kin Saud University, Riyadh, Saudi Arabia
18Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
19Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
20Weill Medical College-Cornell, New York, RI
21Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
22Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
23University of Colorado Cancer Center, Aurora, CO
24University of Colorado, Aurora, CO
25Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
26Sidney Kimmel Cancer Center, Dept. of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
27Hematology, Yale Cancer Center, New Haven, CT
28Siteman Biostatistics Shared Resource, Washington University in St. Louis, Saint Louis

8:15 AM

Yan Gao, MD, PhD1*, Huiqiang Huang, MD, PhD1, Xiaoxiao Wang2*, Bing Bai2*, Yunhong Huang, MD, PhD3*, Haiyan Yang, MD, PhD4*, QingYuan Zhang, MD5*, Yufu Li6*, Yan Li7*, Min Zhou, PhD8*, Runxiang Yang9*, Bing Xu10*, Lihong Liu, MD11*, Yu Yang, MD, PhD12*, Zhigang Peng13*, Ding Yu14*, Hui Zhou, MD, PhD15*, Rong yan Zhang16*, Huilai Zhang, MD, PhD17*, Junyuan Qi, MD18*, Yaming Xi19*, Xiaojing Xing20*, Zhao Wang, MD21*, Hongmei Jing22*, Xiaohong Zhang23*, Liping Ma24*, Hongyan Jin25*, Hongxia Yao, P.hD26*, Yuerong Shuang27*, Xuefang Xia28*, Jianfei Xue29* and Chunlei Li29*

1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
2Cancer Center of Sun Yat-sen University, Guangzhou, China
3Department of Lymphoma, Guizhou Cancer Hospital, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
4Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou, China
5Harbin Medical University Cancer Hospital, Harbin, China
6Henan Tumor Hospital, Zhengzhou, China
7The First Hospital of China Medical University, Shenyang, China
8Tumor hospital affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China
9Yunnan Cancer Hospital, Kunming, China
10Department of Hematology, The first Affiliated Hosptial of Xiamen University, Xiamen, China
11The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
12Department of Lymphoma, Fujian Provincial Cancer Hospital, Fuzhou, China
13First Affiliated Hospital of Guangxi Medical University, NANING, China
14Hubei Cancer Hospital, Wuhan, China
15Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China
16The First Affiliated Hospital of Nanchang University, Nanchang, China
17Tianjin Medical University Cancer Insititute&Hospital, Tianjin, China
18Blood Disease Hospital, Tianjin, China
19Lanzhou University First Hospital, Lanzhou, China
20Liaoning Cancer Hospital, Shenyang, China
21Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
22Peking University Third Hospital, Beijing, China
23Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China
24Sun Yat-sen Memorial,Sun Yat-sen University, GUANGZHOU, China
25Wuhan Puren Hospital, Wuhan, China
26Department of Hematology, Hainan General Hospital, Haikou, China
27JIANGXI CANCER HOSPITAL, Nanchang, China
28CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Beijing, China
29CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, China

8:30 AM

Christiane Querfeld, MD, PhD1,2, Basem M. William, MD, MRCP3, Lubomir Sokol, MD, PhD4, Oleg Akilov, MD5*, Brian Poligone, MD, PhD6*, Jasmine Zain, MD7, Yutaka Tagaya, MD, PhD8* and Nazli Azimi, PhD, PharmD9*

1Beckman Research Institute, City of Hope Medical Center, Duarte, CA
2Beckman Research Institute, Toni Stephenson Lymphoma Center, City of Hope, Duarte, CA
3The Ohio State University Comprehensive Cancer Center, Columbus, OH
4H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Dept. of Dermatology, University of Pittsburgh, Pittsburgh, PA
6Rochester Skin Lymphoma Center, Fairport, NY
7Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
8Institute for Human Virology, University of Maryland, Baltimore, MD
9Bioniz Therapeutics, Inc., Irvine, CA

8:45 AM

Barbara Pro, MD1, Jonathan E. Brammer, MD2, Carla Casulo, MD3, Eric Jacobsen, MD4*, Monica Mead, MD, BS5, Neha Mehta-Shah, MD6, Jasmine M. Zain, MD7, Pier Luigi Zinzani, MD8, Stephanie Lustgarten, PhD9*, Hagop Youssoufian, MD9* and Steven M. Horwitz, MD10

1Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
2The Ohio State University James Comprehensive Cancer Center, Columbus, OH
3Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
4Dana Farber Cancer Institute/Harvard, Boston, MA
5UCLA Medical Center, Santa Monica, CA
6Washington University School of Medicine in St. Louis, Saint Louis, MO
7City of Hope Comprehensive Cancer Center, Duarte, CA
8Institute of Hematology, University of Bologna, Bologna, Italy
9Verastem Oncology, Needham, MA
10Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH